REG - Induction Healthcare - Results of 2022 Annual General Meeting

Induction HealthcareAnnouncement

11/01/2023 13:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230111:nRSK4226Ma&default-theme=true

RNS Number : 4226M  Induction Healthcare Group PLC   11 January 2023

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Results of 2022 Annual General Meeting ("AGM")

Induction Healthcare (AIM: INHC), a leading virtual care platform driving
digital transformation of healthcare systems worldwide, held its AGM today at
50 Liverpool Street, London EC2M 7PY at 9.30am (GMT).

 

The poll results on each resolution proposed are available on the Company
website.

 

All Ordinary Resolutions were passed. Special Resolutions 8, 9 and 10 did not
pass. The Board notes the decision of shareholders in relation to these
resolutions and will consult with shareholders to gain further feedback. Even
so, the Board remains clear on the need to tightly manage costs and execute a
plan ensuring the Group is correctly sized and on target to deliver a cash
breakeven position during FY24.

 

 

ENQUIRIES

 

 Induction                                                 Via Walbrook PR Ltd: induction@walbrookpr.com

 Christopher Samler, Executive
 Chair

 Paul Tambeau, Chief Operating Officer

 Singer Capital Markets (Nominated Adviser and Broker)     +44 (0)20 7496 3000
 Philip Davies

 Walbrook PR Ltd                                           +44 (0)20 7933 8780 or induction@walbrookpr.com
 Alice Woodings / Paul McManus                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

 

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGEAAFFFENDEFA